Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial

Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial

Bibliographic Details
Main Authors: Brunner, Richard, Rinner, Walter, Haberler, Christine, Kitzberger, Reinhard, Sycha, Thomas, Herkner, Harald, Warszawska, Joanna, Madl, Christian, Holzinger, Ulrike
Format: Online
Language:English
Published: BioMed Central 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056097/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056097/

Similar Items